DENA KOCH: Open Payments
NPI 1679251839 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 43 payments from 9 companies in 2025. Trend: 2023 $81 · 2024 $550 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $359 |
| Corium, LLC | 8 | $127 |
| Lundbeck LLC | 4 | $78 |
| Teva Pharmaceuticals USA, Inc. | 3 | $62 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Bausch Health US, LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
Products named: VRAYLAR, Azstarys, REXULTI, HETLIOZ, UZEDY, CAPLYTA, AUSTEDO XR, APLENZIN.
Industry payments across KY — which companies pay providers there.
